Beijing GenomePrecision Technology Co.
Latest round
- Series C
Last raised
- Apr 2021
Total raised
- $20M
Investors
- 16
About Beijing GenomePrecision Technology Co.
, Ltd., Ltd. specializes in molecular diagnostics. The CEO and founder, Feng Ye, has a history of involvement in biotechnology enterprises., Ltd. specializes in molecular diagnostics, including areas such as hematological oncology and tumor immunotherapy.The company's business model operates through B2B transactions with healthcare providers, hospitals, and research institutions for specialized molecular diagnostic services., Ltd. The company plans to expand its product line and is exploring new markets for its diagnostic technologies, with a focus on specific regions yet to be disclosed.
Who invested in Beijing GenomePrecision Technology Co.
16 investors across 5 rounds
See all investors in Beijing GenomePrecision Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing GenomePrecision Technology Co.
Who invested in Beijing GenomePrecision Technology Co.?
Beijing GenomePrecision Technology Co. has 16 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing GenomePrecision Technology Co. raised?
Beijing GenomePrecision Technology Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing GenomePrecision Technology Co. last raise money?
Beijing GenomePrecision Technology Co.'s most recent round on record is a Series C, in Apr 2021.
What does Beijing GenomePrecision Technology Co. do?
Beijing GenomePrecision Technology Co. is a biotechnology company.
Where is Beijing GenomePrecision Technology Co. headquartered?
Beijing GenomePrecision Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing GenomePrecision Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing GenomePrecision Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing GenomePrecision Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.